Rivian Unveils Two, Lower-Priced EVs as It Seeks to Jump-Start Sales
The startup is betting that customers will line up to buy a more affordable version of its EV vehicles.
Chemours Executives Improperly Shifted Deals to Boost Pay, Probe Finds
An investigation has found that the Teflon maker's top executives shifted cash flows at year-end to hit targets that determined their annual stock and bonus awards.
NYCB Slashes Dividend Amid Broader Overhaul
New York Community Bancorp reduced its quarterly dividend to 1 cent a share, part of an overhaul aimed at shoring up confidence in the regional lender.
Kroger is 'committed' to defending the Albertsons merger, and stock surges
Kroger's stock leaped toward a near two-year high Thursday, after the grocery chain reported quarterly profit and same-store sales that beat expectations, and indicated it was still pursuing its acquisition of Albertsons Companies Inc. despite regulatory pushback.
GE's stock rises to 6-year high as GE Aerospace sets $15 billion buyback plan
The stock is on pace for the longest such streak since the nine-week streak that ended Feb. 18, 2011.
Power Lines Sparked Largest Wildfire in Texas History
Xcel Energy said Thursday that it believes its own facilities have been involved in starting massive wildfires still raging in the state of Texas.
Burlington Stores' stock jumps after profit beat, as gross margin improves again
Burlington Stores' stock climbed toward a one-year high Thursday, after the discount apparel retailer reported fiscal fourth-quarter profit and sales that rose above expectations, as gross margin continued to improve and inventories fell.
BJ's delivers Q4 earnings beat but guidance impacted by 'macro-driven uncertainty'
Stock falls early Thursday.
Tesla Stock Falls Again Amid Growth Fears. EV Rival Rivian Rises After Upgrade.
More analysts expressed concern about the Elon Musk-led EV maker's growth.
Novo Nordisk Surges After Early Trial Shows Promise of New Obesity Drug
Shares hit a record after the Danish pharmaceutical giant said the drug could be more effective than blockbuster Wegovy.
(END) Dow Jones Newswires
03-07-24 1515ET